Topiramate 70771-1316-05
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 5, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA207382
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 50 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
70771-1316-05Selected500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1316-5)
Other packages for this product(4)
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1316-1)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1316-3)
10 BLISTER PACK in 1 CARTON (70771-1316-4) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (70771-1316-2)
90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1316-9)